Glenmark Pharmaceuticals has received final approval for generic versions of Loestrin tablets, from the US health regulator.

In a BSE filing the company stated, “Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Hailey 1.5/30 (Norethindrone Acetate and Ethinyl Estradiol tablets USP, 1.5 mg/30 mcg) and Hailey Fe 1.5/30 (Norethindrone Acetate and Ethinyl Estradiol tablets, USP and Ferrous Fumarate tablets, 1.5 mg/30 mcg).”

Further, this product is used to prevent pregnancy and are the generic versions of Allergan Pharmaceuticals’ Loestrin 21 1.5/30 and Loestrin Fe 1.5/30 tablets.

Read EquityPandit’s Technical Analysis of  Nifty Pharma Outlook for the Week